Schmäche, Tim
Fohgrub, Juliane
Klimova, Anna
Laaber, Karin
Drukewitz, Stephan
Merboth, Felix
Hennig, Alexander
Seidlitz, Therese
Herbst, Friederike
Baenke, Franziska
Ada, Anne-Marlen
Groß, Thomas
Wenzel, Carina
Ball, Claudia R.
Praetorius, Christian
Schmidt, Thomas
Ringelband-Schilling, Barbara
Koschny, Ronald
Stenzinger, Albrecht
Roeder, Ingo
Jaeger, Dirk
Zeissig, Sebastian
Welsch, Thilo
Aust, Daniela
Glimm, Hanno
Folprecht, Gunnar
Weitz, Jürgen
Haag, Georg M.
Stange, Daniel E.
Article History
Received: 17 November 2023
Accepted: 19 December 2023
First Online: 10 January 2024
Change Date: 13 May 2024
Change Type: Update
Change Details: This article has been returned to typesetting for post-publication update so that its category label can be updated to Research and the sentence “Open Access funding enabled and organized by Projekt DEAL.” can be added to the Funding section.
Declarations
:
: This study was conducted according to the principles of the Declaration of Helsinki. Human material was collected after providing informed consent within the OPPOSITE trial (ClinicalTrials.gov #NCT03429816) approved by the ethics committee of the TU Dresden (EK 169052018) and University Heidelberg (S-686/2017).
: Albrecht StenzingerConsulting or Advisory role: Aignostics, Amgen, Astra Zeneca, Bayer, BMS, Eli Lilly, Illumina, Incyte, Janssen, MSD, Novartis, Pfizer, Qlucore, Roche, Seattle Genetics, Takeda, Thermo Fisher.Research Funding: Bayer, BMS, Chugai, Incyte.Dirk JaegerConsulting or Advisory role: Amgen, BMS, Cure Vac, Definierens, F. Hoffmann-La Roche, Genmab A-S, Life Science Inkubator and Vaxxim, Zelluna, OncoOne Research Development.Gunnar FolprechtResearch Funding: Merck.Honoraria, Consulting or Advisory Role: Merck, Roche, Amgen, Lilly, Sanofi-Aventis, Servier, Bayer, BMS and MSD.Georg M. HaagConsulting or Advisory role: Bristol-Myers Squibb, MSD Sharp & Dohme, Lilly, Novartis; Daiichi Sankyo; Servier; MSD Sharp & Dohme.Research Funding: Nordic Pharma, Taiho Pharmaceutical, MSD Sharp & Dohme.Travel, Accommodations, Expenses: Bristol-Myers Squibb, Lilly, Servier and MSD Sharp & Dohme.Karin LaaberCurrent Employment: Merck KGaA.Ronald KoschnyHonorary Lectures: Abbvie, Sanofi-Aventis, Bristol-Myers Squibb, Bayer Vital, Norgine.Daniel E. StangeResearch Funding: Ardeypharm.No disclosures were reported by the other authors.